x
Filter:
Filters applied
- Clinical Practice Guidelines and Recommendations
- CADRemove CAD filter
Author
- Allison, Thomas G1
- Basu, Ananda1
- Brundage, Bruce H1
- Chaitman, Bernard R1
- Eagle, Kim A1
- Ewv, Gordon A1
- Fernandes, Regis1
- Fleisher, Lees A1
- Hertzer, Norman R1
- Hurst, R Todd1
- Kopecky, Stephen L1
- Kullo, Iftikhar J1
- Leppo, Jeffrey A1
- Lopez-Jimenez, Francisco1
- Mulvagh, Sharon L1
- Myers, Jonathan1
- Ryan, Thomas1
- Schlant, Robert C1
- Simha, Vinaya1
- Spencer, William H III1
- Spittell, John A Jr1
- Thomas, Randal J1
- Thompson, Warren G1
- Trejo-Gutierrez, Jorge F1
- Twiss, Richard D1
Keyword
- coronary artery disease3
- American College of Cardiology/American Heart Association2
- cardiovascular disease2
- CVD2
- LDL-C2
- low-density lipoprotein cholesterol2
- 4S1
- A to Z1
- ABI1
- ACC1
- ACC/AHA1
- ACC/AHA AHA1
- ACCORD1
- Action to Control Cardiovascular Risk in Diabetes1
- Adult Treatment Panel III1
- AFCAPS-TexCAPS1
- Aggrastat to Zocor1
- AHA1
- Air Force/Texas Coronary Atherosclerosis Prevention Study1
- ALT1
- ASCOT-LLA1
- ASCVD1
- ASPEN1
- ATP III1
Clinical Practice Guidelines and Recommendations
3 Results
- Special article
A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease Risk in Adults: Filling the Gaps
Mayo Clinic ProceedingsVol. 89Issue 9p1257–1278Published online: August 13, 2014- Francisco Lopez-Jimenez
- Vinaya Simha
- Randal J. Thomas
- Thomas G. Allison
- Ananda Basu
- Regis Fernandes
- and others
Cited in Scopus: 36The American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Practice Guidelines has recently released the new cholesterol treatment guideline. This update was based on a systematic review of the evidence and replaces the previous guidelines from 2002 that were widely accepted and implemented in clinical practice. The new cholesterol treatment guideline emphasizes matching the intensity of statin treatment to the level of atherosclerotic cardiovascular disease (ASCVD) risk and replaces the old paradigm of pursuing low-density lipoprotein cholesterol targets. - Commentary
New American Heart Association/American College of Cardiology Guidelines on Cardiovascular Risk: When Will Fitness Get the Recognition It Deserves?
Mayo Clinic ProceedingsVol. 89Issue 6p722–726Published online: May 5, 2014- Jonathan Myers
Cited in Scopus: 21During the American Heart Association (AHA) Scientific Sessions in November 2013, the AHA and the American College of Cardiology (ACC) jointly released new guidelines for the prevention and treatment of coronary artery disease (CAD). The guidelines focused on the assessment of cardiovascular risk1 and the treatment of blood lipids2 and received a great deal of attention from both the media and professional journals. These organizations are among the most experienced and qualified to develop guidelines, and their guidelines and scientific statements set the standard for clinical practice. - Special Article
Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac Surgery: An Abridged Version of the Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Mayo Clinic ProceedingsVol. 72Issue 6p524–531Published in issue: June, 1997- Kim A. Eagle
- Writing Committee
- Bruce H. Brundage
- Bernard R. Chaitman
- Gordon A. Ewv
- Lees A. Fleisher
- and others
Cited in Scopus: 28Purpose of These Guidelines.— These guidelines are intended for physicians involved in the preoperative, operative, and postoperative care of patients undergoing noncardiac surgery. They provide a framework for considering cardiac risk of noncardiac surgery in various patient and operative situations. They strive to incorporate the current information on perioperative risk and how this knowledge can be used to treat individual patients. The methods used to develop these guidelines are described in the Appendix.